Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Vaccines|July 21, 2019
From Vaccine Vector to Oncomodulation: Understanding the Complex Interplay between CMV and CancerNicole A Wilski, Christopher M SnyderHuman Vaccines & Immunotherapeutics|June 13, 2017
Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunityDan A Erkes, Nicole A Wilski, Christopher M SnyderCancer Discovery|January 16, 2021
Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer ImmunotherapySheera R Rosenbaum, Nicole A Wilski, Andrew E AplinJournal of Virology|August 4, 2019
Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the TumorNicole A Wilski, Christina Del Casale, Timothy J Purwin, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2017
Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 ExpressionDan A Erkes, Corinne J Smith, Nicole A Wilski, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2020
STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor ImmunityNicole A Wilski, Colby Stotesbury, Christina Del Casale, et al.Pharmaceutics|August 28, 2025
A Dual-Payload Bispecific ADC Improved Potency and Efficacy over Single-Payload Bispecific ADCsNicole A Wilski, Peter Haytko, Zhengxia Zha, et al.Cancer Research|June 3, 2022
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant MelanomaWeijia Cai, Mai Q Nguyen, Nicole A Wilski, et al.Molecular Cancer Research : MCR|August 31, 2022
Raptinal Induces Gasdermin E-Dependent Pyroptosis in Naïve and Therapy-Resistant MelanomaMegane Vernon, Nicole A Wilski, Daniel Kotas, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 20, 2016
Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term ImmunityDan A Erkes, Guangwu Xu, Constantine Daskalakis, et al.Pageof 2